Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical Trial.
Tavares CAM, Azevedo LCP, Rea-Neto Á, Campos NS, Amendola CP, Kozesinski-Nakatani AC, David-João PG, Lobo SM, Filiponi TC, Almeida GMB, Bergo RR, Guimarães-Júnior MRR, Figueiredo RC, Castro JR, Schuler CJ, Westphal GA, Carioca ACR, Monfradini F, Nieri J, Neves FMO, Paulo JA, Albuquerque CSN, Silva MCR, Kosiborod MN, Pereira AJ, Damiani LP, Corrêa TD, Serpa-Neto A, Berwanger O, Zampieri FG; DEFENDER Investigators. Tavares CAM, et al. Among authors: silva mcr. JAMA. 2024 Aug 6;332(5):401-411. doi: 10.1001/jama.2024.10510. JAMA. 2024. PMID: 38873723 Clinical Trial.
A multi-evidence approach in an Amazonian river based on land use, water quality, histopathological effects and habitat selection behavior in fish.
C V R Silva D, Silva GC, Siqueira-Silva DH, Bazzan T, Silva HTL, Silva MCR, Bérgamo AL, Freitas JVR, Porfírio AEP, Pelegrini GH, Araújo CVM. C V R Silva D, et al. Among authors: silva mcr. Chemosphere. 2024 Aug;361:142492. doi: 10.1016/j.chemosphere.2024.142492. Epub 2024 Jun 1. Chemosphere. 2024. PMID: 38830469
Dapagliflozin in patients with critical illness: rationale and design of the DEFENDER study.
Tavares CAM, Azevedo LCP, Rea-Neto Á, Campos NS, Amendola CP, Bergo RR, Kozesinski-Nakatani AC, David-João PG, Westphal GA, Guimarães Júnior MRR, Lobo SMA, Tavares MS, Dracoulakis MDA, Souza GM, Almeida GMB, Gebara OCE, Tomba PO, Albuquerque CSN, Silva MCR, Pereira AJ, Damiani LP, Corrêa TD, Serpa-Neto A, Berwanger O, Zampieri FG. Tavares CAM, et al. Among authors: silva mcr. Crit Care Sci. 2023 Dec 22;35(3):256-265. doi: 10.5935/2965-2774.20230129-en. eCollection 2023. Crit Care Sci. 2023. PMID: 38133155 Free PMC article.
Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial.
Fonseca HAR, Furtado RHM, Zimerman A, Lemos PA, Franken M, Monfardini F, Pedrosa RP, Patriota RLS, Passos LCS, Dall'Orto FTC, Hoffmann Filho CR, Nascimento BR, Baldissera FA, Pereira CAC, Caramori PRA, de Andrade PB, Esteves C, Salim EF, da Silva JH, Pedro IC, Silva MCR, de Pedri EH, Carioca ACRD, de Piano LPA, Albuquerque CSN, Moia DDF, Momesso RGRAP, Machado FP, Damiani LP, Soares RVP, Schettino GP, Rizzo LV, Nicolau JC, Berwanger O. Fonseca HAR, et al. Among authors: silva mcr. Eur Heart J. 2022 Nov 1;43(41):4378-4388. doi: 10.1093/eurheartj/ehac472. Eur Heart J. 2022. PMID: 36030400 Clinical Trial.